The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments
Open accessAbstract
Cyclic nucleotide phosphodiesterases (PDEs) that specifically inactivate the intracellular messengers cAMP and cGMP in a compartmentalized manner represent an important enzyme class constituted by 11 gene‐related families of isozymes (PDE1 to PDE11). Downstream receptors, PDEs play a major role in controlling the signalosome at various levels of phosphorylations and protein/protein interactions. Due to the multiplicity of isozymes, their various intracellular regulations and their different cellular and subcellular distributions, PDEs represent interesting targets in intracellular pathways. Therefore, the investigation of PDE isozyme alterations related to various pathologies and the design of specific PDE inhibitors might lead to the development of new specific therapeutic strategies in numerous pathologies. This manuscript (i) overviews the different PDEs including their endogenous regulations and their specific inhibitors; (ii) analyses the intracellular implications of PDEs in regulating signalling cascades in pathogenesis, exemplified by two diseases affecting cell cycle and proliferation; and (iii) discusses perspectives for future therapeutic developments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
de Rooij, J., Zwartkruis, F. J. T., Verheijen, M. H. G., Cool, R. H., Nijman, S. M. B., Wittinghofer, A., & Bos, J. L. (1998) · Nature · doi:10.1038/24884 · Cited by 1,969
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Cyclic Nucleotide-Gated Ion Channels
Kaupp, U. B., & Seifert, R. (2002) · Physiological Reviews · doi:10.1152/physrev.00008.2002 · Cited by 1,143
AKAP signalling complexes: focal points in space and time
Wong, W., & Scott, J. D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1527 · Cited by 1,073 · cited 2×
“…via specific A kinase anchoring proteins (AKAPs; Dell’Acqua and Scott, 1997; Moorthy et al., 2011) or G kinase anchoring proteins (GKAPs; Vo et al., 1998; Casteel et al., 2010; Manneville et al., 2010), they participate in intracellular signalling compartmentalization (Wong and Scott, 2004).”
BackgroundCyclic nucleotide research — still expanding after half a century
Beavo, J. A., & Brunton, L. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm911 · Cited by 903
Lugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
Self-citationOverview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 796
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
Michelakis, E., Tymchak, W., Lien, D., Webster, L., Hashimoto, K., & Archer, S. (2002) · Circulation · doi:10.1161/01.cir.0000016641.12984.dc · Cited by 577
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module
Dodge, K. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1921 · Cited by 507
Wallis, R. M., Corbin, J. D., Francis, S. H., & Ellis, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00042-9 · Cited by 504
Epac: Defining a New Mechanism for cAMP Action
Gloerich, M., & Bos, J. L. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105714 · Cited by 473
Sleep deprivation impairs cAMP signalling in the hippocampus
Vecsey, C. G., Baillie, G. S., Jaganath, D., Havekes, R., Daniels, A., Wimmer, M., Huang, T., Brown, K. M., Li, X.-Y., Descalzi, G., et al. (2009) · Nature · doi:10.1038/nature08488 · Cited by 454 · cited 1×
“Recent studies demonstrate the interest of PDE inhibitors to treat and to reverse heart hypertrophy (Takimoto et al., 2005), to enhance cognition (Reneerkens et al., 2009) and to treat sleep deprivation (Vecsey et al., 2009).”
BackgroundA simple procedure for the long-term cultivation of chicken embryos
Auerbach, R., Kubai, L., Knighton, D., & Folkman, J. (1974) · Developmental Biology · doi:10.1016/0012-1606(74)90316-9 · Cited by 439
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Houslay, M. D. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.007 · Cited by 430
Treatment-Related Mortality With Bevacizumab in Cancer Patients: A Meta-analysis
Ranpura, V., Hapani, S., & Wu, S. (2011) · JAMA · doi:10.1001/jama.2011.51 · Cited by 428
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Tsai, E. J., & Kass, D. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.009 · Cited by 420
Boswell‐Smith, V., Spina, D., & Page, C. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706495 · Cited by 405
Fujishige, K., Kotera, J., Michibata, H., Yuasa, K., Takebayashi, S.-I., Okumura, K., & Omori, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18438 · Cited by 404
Burgin, A. B., Magnusson, O. T., Singh, J., Witte, P., Staker, B. L., Bjornsson, J. M., Thorsteinsdottir, M., Hrafnsdottir, S., Hagen, T., Kiselyov, A. S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1598 · Cited by 397
Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension
Wilkens, H., Guth, A., König, J., Forestier, N., Cremers, B., Hennen, B., Böhm, M., & Sybrecht, G. W. (2001) · Circulation · doi:10.1161/hc3601.096826 · Cited by 392
Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.944694 · Cited by 382
Maurice, D. H., & Haslam, R. J. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10974-7 · Cited by 351
Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase
Fisher, D. A., Smith, J. F., Pillar, J. S., Denis, S. H. S., & Cheng, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15559 · Cited by 341
PDE4 inhibitors: current status
Spina, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.307 · Cited by 340
Boess, F. G., Hendrix, M., van der Staay, F.-J., Erb, C., Schreiber, R., van Staveren, W., de Vente, J., Prickaerts, J., Blokland, A., & Koenig, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.040 · Cited by 330
Hatzelmann, A., Morcillo, E. J., Lungarella, G., Adnot, S., Sanjar, S., Beume, R., Schudt, C., & Tenor, H. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.03.011 · Cited by 320
Bolger, G., Michaeli, T., Martins, T., St John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M., & Ferguson, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6558 · Cited by 315
Cyclic Nucleotide-Dependent Protein Kinases: Intracellular Receptors for cAMP and cGMP Action
Francis, S. H., & Corbin, J. D. (1999) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369991239213 · Cited by 305
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
Lugnier, C., Schoeffter, P., Le Bec, A., Strouthou, E., & Stoclet, J. C. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90333-3 · Cited by 301
Self-citationSchaeffer, H. J., & Schwender, C. F. (1974) · Journal of Medicinal Chemistry · doi:10.1021/jm00247a002 · Cited by 294
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding
Martinez, S. E., Wu, A. Y., Glavas, N. A., Tang, X.-B., Turley, S., Hol, W. G. J., & Beavo, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192374899 · Cited by 286
Schmidt, C. J., Chapin, D. S., Cianfrogna, J., Corman, M. L., Hajos, M., Harms, J. F., Hoffman, W. E., Lebel, L. A., McCarthy, S. A., Nelson, F. R., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132910 · Cited by 284
Siuciak, J. A., Chapin, D. S., Harms, J. F., Lebel, L. A., McCarthy, S. A., Chambers, L., Shrikhande, A., Wong, S., Menniti, F. S., & Schmidt, C. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.013 · Cited by 278
Dell'Acqua, M. L., & Scott, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.12881 · Cited by 271
Grauer, S. M., Pulito, V. L., Navarra, R. L., Kelly, M. P., Kelley, C., Graf, R., Langen, B., Logue, S., Brennan, J., Jiang, L., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155994 · Cited by 269
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Reneerkens, O. A. H., Rutten, K., Steinbusch, H. W. M., Blokland, A., & Prickaerts, J. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1273-x · Cited by 266
Cyclic Nucleotide-Gated Channels
Biel, M., & Michalakis, S. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5_7 · Cited by 265
Forte, L. R., Thorne, P. K., Eber, S. L., Krause, W. J., Freeman, R. H., Francis, S. H., & Corbin, J. D. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.3.c607 · Cited by 263
Cyclic Nucleotide-Gated Ion Channels
Matulef, K., & Zagotta, W. N. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.110701.154854 · Cited by 243
Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism
Jeon, K.-I., Xu, X., Aizawa, T., Lim, J. H., Jono, H., Kwon, D.-S., Abe, J.-I., Berk, B. C., Li, J.-D., & Yan, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914414107 · Cited by 241
Takimoto, E., Champion, H. C., Belardi, D., Moslehi, J., Mongillo, M., Mergia, E., Montrose, D. C., Isoda, T., Aufiero, K., Zaccolo, M., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000152262.22968.72 · Cited by 219
In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits.
Anant, J. S., Ong, O. C., Xie, H. Y., Clarke, S., O'Brien, P. J., & Fung, B. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48336-6 · Cited by 218
SCHWABE, U., MIYAKE, M., OHGA, Y., & DALY, J. W. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10862-6 · Cited by 218
Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation
Kass, D. A., Champion, H. C., & Beavo, J. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.162511 · Cited by 217
Arozarena, I., Sanchez-Laorden, B., Packer, L., Hidalgo-Carcedo, C., Hayward, R., Viros, A., Sahai, E., & Marais, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.10.029 · Cited by 212
Cyclic AMP is both a pro‐apoptotic and anti‐apoptotic second messenger
Insel, P. A., Zhang, L., Murray, F., Yokouchi, H., & Zambon, A. C. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02273.x · Cited by 203
Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γ
Perino, A., Ghigo, A., Ferrero, E., Morello, F., Santulli, G., Baillie, G. S., Damilano, F., Dunlop, A. J., Pawson, C., Walser, R., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.030 · Cited by 200
Daugan, A., Grondin, P., Ruault, C., Le Monnier de Gouville, A.-C., Coste, H., Kirilovsky, J., Hyafil, F., & Labaudinière, R. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030056e · Cited by 195
Giampà, C., Laurenti, D., Anzilotti, S., Bernardi, G., Menniti, F. S., & Fusco, F. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013417 · Cited by 184
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents
van der Staay, F. J., Rutten, K., Bärfacker, L., DeVry, J., Erb, C., Heckroth, H., Karthaus, D., Tersteegen, A., van Kampen, M., Blokland, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.005 · Cited by 177
Mechanisms of Protein Kinase A Anchoring
(2010) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(10)83005-9 · Cited by 175
Grandoch, M., Roscioni, S. S., & Schmidt, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00458.x · Cited by 174
Cyclic Nucleotide Phosphodiesterases in Health and Disease
(2006) · CRC Press eBooks · doi:10.1201/9781420020847 · Cited by 173
Baillie, G. S., MacKenzie, S. J., McPhee, I., & Houslay, M. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703636 · Cited by 170
Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart
Lu, Z., Xu, X., Hu, X., Lee, S., Traverse, J. H., Zhu, G., Fassett, J., Tao, Y., Zhang, P., Remedios, C. D., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.906818 · Cited by 167
Networking with AKAPs: Context-dependent Regulation of Anchored Enzymes
Welch, E. J., Jones, B. W., & Scott, J. D. (2010) · Molecular Interventions · doi:10.1124/mi.10.2.6 · Cited by 166
Yan, C., Zhao, A. Z., Bentley, J. K., & Beavo, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25699 · Cited by 164
EPAC proteins transduce diverse cellular actions of cAMP
Borland, G., Smith, B. O., & Yarwood, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00087.x · Cited by 163
Phototransduction: crystal clear
Ridge, K. D., Abdulaev, N. G., Sousa, M., & Palczewski, K. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00172-5 · Cited by 163 · cited 2×
“In contrast to other PDE families, the PDE6 family is restricted to retinal rod and cone cells (Miki et al., 1975; Ridge et al., 2003) and to pineal gland (Morin et al., 2001).”
BackgroundCalcium/calmodulin-activated phosphodiesterase expressed in olfactory receptor neurons
Borisy, F., Ronnett, G., Cunningham, A., Juilfs, D., Beavo, J., & Snyder, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-00915.1992 · Cited by 162
Baillie, G. S., Huston, E., Scotland, G., Hodgkin, M., Gall, I., Peden, A. H., MacKenzie, C., Houslay, E. S., Currie, R., Pettitt, T. R., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108353200 · Cited by 161
Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1)
Kakkar, R., Raju, R. V. S., & Sharma, R. K. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050364 · Cited by 154
Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line
Wunder, F., Tersteegen, A., Rebmann, A., Erb, C., Fahrig, T., & Hendrix, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017608 · Cited by 149
Hutson, P. H., Finger, E. N., Magliaro, B. C., Smith, S. M., Converso, A., Sanderson, P. E. J., Mullins, D. E., Hyde, L. A., Eschle, B. K., Turnbull, Z., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.009 · Cited by 146
Yuasa, K., Kotera, J., Fujishige, K., Michibata, H., Sasaki, T., & Omori, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003041200 · Cited by 145
Manning, C. D., Burman, M., Christensen, S. B., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702911 · Cited by 145
Alhosin, M., Abusnina, A., Achour, M., Sharif, T., Muller, C. D., Peluso, J., Chataigneau, T., Lugnier, C., Schini‐Kerth, V. B., Bronner, C., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.015 · Cited by 144
Self-citationIsoforms of Cyclic Nucleotide Phosphodiesterase PDE3A in Cardiac Myocytes
Wechsler, J., Choi, Y. H., Krall, J., Ahmad, F., Manganiello, V. C., & Movsesian, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203647200 · Cited by 141
Seybold, J., Thomas, D., Witzenrath, M., Boral, Ş., Hocke, A. C., Bürger, A., Hatzelmann, A., Tenor, H., Schudt, C., Krüll, M., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2729 · Cited by 135
Beard, M., Olsen, A. E., Jones, R. E., Erdoğan, S., Houslay, M. D., & Bolger, G. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10349 · Cited by 132
Lugnier, C., & Schini‐Kerth, V. B. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90650-a · Cited by 130
Self-citationDual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
Banner, K. H., & Press, N. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00170.x · Cited by 128
Cyclic GMP and Nitric Oxide Synthase in Aging and Alzheimer's Disease
Domek-Łopacińska, K., & Strosznajder, J. B. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8104-x · Cited by 127
Nagel, D. J., Aizawa, T., Jeon, K., Liu, W., Mohan, A. M., Wei, H., Miano, J. M., Florio, V. A., Gao, P., Korshunov, V. A., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000215576.27615.fd · Cited by 127
Libé, R., Horvath, A., Vezzosi, D., Fratticci, A., Coste, J., Perlemoine, K., Ragazzon, B., Guillaud-Bataille, M., Groussin, L., Clauser, É., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1704 · Cited by 123
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
Rybalkin, S. D., Rybalkina, I. G., Beavo, J. A., & Bornfeldt, K. (2002) · Circulation Research · doi:10.1161/hh0202.104108 · Cited by 123
Netherton, S. J., & Maurice, D. H. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004853 · Cited by 123
Barber, R., Baillie, G. S., Bergmann, R., Shepherd, M. C., Sepper, R., Houslay, M. D., & Heeke, G. V. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00384.2003 · Cited by 121
Signal transducing membrane complexes of photoreceptor outer segments
Wensel, T. G. (2008) · Vision Research · doi:10.1016/j.visres.2008.03.010 · Cited by 120
Murray, F., Patel, H. H., Suda, R. Y. S., Zhang, S., Thistlethwaite, P. A., Yuan, J. X. ‐., & Insel, P. A. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00190.2006 · Cited by 120
Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta
Ahn, H. S., Crim, W. N., Romano, M., Sybertz, E. J., & Pitts, B. J. R. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90631-x · Cited by 117
McCahill, A., McSorley, T., Huston, E., HILL, E., Lynch, M. J., Gall, I., Keryer, G., Lygren, B., Taskén, K., & Vanheeke, G. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.003 · Cited by 115
Cyclic Nucleotide Binding GAF Domains from Phosphodiesterases: Structural and Mechanistic Insights
Heikaus, C. C., Pandit, J., & Klevit, R. E. (2009) · Structure · doi:10.1016/j.str.2009.07.019 · Cited by 112
Pande, R. L., Hiatt, W. R., Zhang, P. G. Y., Hittel, N., & Creager, M. A. (2010) · Vascular Medicine · doi:10.1177/1358863x10361545 · Cited by 112
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors
Favot, L., Keravis, T. M., Holl, V., Bec, A. L., & Lugnier, C. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0084 · Cited by 110
Self-citationThe role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis
Snyder, P. B., Esselstyn, J. M., Loughney, K., Wolda, S. L., & Florio, V. A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400362-jlr200 · Cited by 110
Tinsley, H. N., Gary, B. D., Keeton, A. B., Zhang, W., Abadi, A., Reynolds, R. C., & Piazza, G. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0758 · Cited by 105
PDE4 inhibitors: a review of current developments (2005 – 2009)
Pagès, L., Gavaldà, A., & Lehner, M. D. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903313753 · Cited by 104
Role of phosphodiesterase 5 in synaptic plasticity and memory
Puzzo, D., Sapienza, S., Arancio, O., & Palmeri, A. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2447 · Cited by 104
Sin, Y. Y., Edwards, H. V., Li, X., Day, J. P., Christian, F., Dunlop, A. J., Adams, D. R., Zaccolo, M., Houslay, M. D., & Baillie, G. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.02.006 · Cited by 103
Tsai, L.-C. L., Shimizu‐Albergine, M., & Beavo, J. A. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069104 · Cited by 100
TURKO, V. I., Sharron, H. F., & CORBIN, D. J. (1998) · Biochemical Journal · doi:10.1042/bj3290505 · Cited by 94
Kelly, M. P., Logue, S. F., Brennan, J. A., Day, J. P., Lakkaraju, S., Jiang, L., Zhong, X., Tam, M., Rizzo, S. J. S., Platt, B. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000730107 · Cited by 93
Bepridil and flunarizine as calmodulin inhibitors
Lugnier, C., Follénius-Wund, A., Gérard, D., & Stoclet, J. C. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90128-6 · Cited by 92
Self-citationMolecular organization of bovine rod cGMP-phosphodiesterase 6
Kameni-Tcheudji, J., Lebeau, L., Virmaux, N., Maftei, C. G., Cote, R., Lugnier, C., & Schultz, P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4813 · Cited by 92
Self-citationRichter, W., & Conti, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312687200 · Cited by 90
Manneville, J., Jéhanno, M., & Etienne‐Manneville, S. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201002151 · Cited by 88
Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling
Masood, A., Huang, Y., HajjHussein, H., Xiao, L., Li, H., Wang, W., Hamza, A., Zhan, C., & O’Donnell, J. M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156729 · Cited by 87
The cAMP Signaling Pathway as a Therapeutic Target in Lymphoid Malignancies
Lerner, A., Kim, D. H., & Lee, R. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009057627 · Cited by 78
Mokni, W., Keravis, T. M., Étienne-Selloum, N., Walter, A., Kane, M. O., Schini‐Kerth, V. B., & Lugnier, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014227 · Cited by 75
Self-citationZmuda‐Trzebiatowska, E., Oknianska, A., Manganiello, V. C., & Degerman, E. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.007 · Cited by 75
Eckly, A. E., & Lugnier, C. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17009.x · Cited by 72
Self-citationRentero, C., Monfort, A., & Puigdomènech, P. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00021-4 · Cited by 72
Cooperative and uncooperative cyclic-nucleotide-gated ion channels
Cukkemane, A., Seifert, R., & Kaupp, U. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.004 · Cited by 71
PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER
Vang, A. G., Ben-Sasson, S. Z., Dong, H., Kream, B. E., DeNinno, M. P., Claffey, M. M., Housley, W., Clark, R. B., Epstein, P. M., & Brocke, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012011 · Cited by 70
Souness, J. E., Diocee, B. K., Martin, W., & Moodie, S. A. (1990) · Biochemical Journal · doi:10.1042/bj2660127 · Cited by 67
Wilson, L. S., Baillie, G. S., Pritchard, L. M., Umana, B., Terrin, A., Zaccolo, M., Houslay, M. D., & Maurice, D. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217026 · Cited by 62
Phosphodiesterase 11: a brief review of structure, expression and function
Makhlouf, A. A., Kshirsagar, A. S., & NIEDERBERGER, C. S. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901441 · Cited by 62
Palmer, D., Jimmo, S. L., Raymond, D. R., Wilson, L. S., Carter, R. L., & Maurice, D. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606936200 · Cited by 54
Lugnier, C., Stierlé, A., Beretz, A., et al. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91091-4 · Cited by 53
Self-citationPhosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428
Rubio, M. P., Campbell, D. G., Morrice, N. A., & MacKintosh, C. (2005) · Biochemical Journal · doi:10.1042/bj20051103 · Cited by 51
Nilsson, R., Ahmad, F., Swärd, K., Andersson, U., Weston, M. C., Manganiello, V., & Degerman, E. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.01.010 · Cited by 51
Francis, S. H., Morris, G. Z., & Corbin, J. D. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.4 · Cited by 50
Giorgi, M., Melchiorri, G., Nuccetelli, V., D'Angelo, V., Martorana, A., Sorge, R., Castelli, V., Bernardi, G., & Sancesario, G. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.006 · Cited by 50
Ahmad, F., Lindh, R., Tang, Y., Ruishalme, I., Öst, A., Sahachartsiri, B., Strålfors, P., Degerman, E., & Manganiello, V. (2009) · Biochemical Journal · doi:10.1042/bj20090842 · Cited by 50
Geoffroy, V., Fouque, F., Nivet‐Antoine, V., Clot, J., Lugnier, C., Desbuquois, B., & Benelli, C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00123.x · Cited by 48
Self-citationRegulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review
Sharma, R. K., Das, S. B., Lakshmikuttyamma, A., Selvakumar, P., & Shrivastav, A. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.1.95 · Cited by 48
Identification of cGMP-Dependent Protein Kinase Anchoring Proteins (GKAPs)
Vo, N., Gettemy, J. M., & Coghlan, V. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8722 · Cited by 47
Tiwari, S., Dong, H., Kim, E. J., Weintraub, L. R., Epstein, P. M., & Lerner, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.10.009 · Cited by 47
Huston, E., Gall, I., Houslay, T. M., & Houslay, M. D. (2006) · Journal of Cell Science · doi:10.1242/jcs.03106 · Cited by 46
Hayashi, M., Shimada, Y., Nishimura, Y., Hama, T., & Tanaka, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02371-9 · Cited by 45
Kadoshima-Yamaoka, K., Murakawa, M., Goto, M., Tanaka, Y., Inoue, H., Murafuji, H., Nagahira, A., Hayashi, Y., Nagahira, K., Miura, K., et al. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.01.004 · Cited by 43
Berger, K., Lindh, R., Wierup, N., Zmuda‐Trzebiatowska, E., Lindqvist, A., Manganiello, V. C., & Degerman, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004671 · Cited by 43
Moorthy, B. S., Gao, Y., & Anand, G. S. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002295 · Cited by 43
Theophylline, a new inducer of apoptosis in B‐CLL: role of cyclic nucleotides
Mentz, F., Merle‐Béral, H., Ouaaz, F., & Binet, J. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05225.x · Cited by 43
Cyclic GMP-Hydrolyzing Phosphodiesterases
Francis, S. H., Corbin, J. D., & Bischoff, E. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5_16 · Cited by 42
Lamas, M., & Sassone‐Corsi, P. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.10.9988 · Cited by 41
Wang, H., Robinson, H. H., & Ke, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141614 · Cited by 40
Day, J. P., Lindsay, B., Riddell, T., Jiang, Z., Allcock, R. W., Abraham, A., Sookup, S., Frank, C., Bogum, J., Martin, E. K., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200070e · Cited by 40
Hanson, M. S., Stephenson, A. H., Bowles, E. A., & Sprague, R. S. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009206 · Cited by 38
Cote, R. (2006) · CRC Press eBooks · doi:10.1201/9781420020847-8 · Cited by 36
A new chemical tool for exploring the physiological function of the PDE2 isozyme
Chambers, R. J., Abrams, K., Garceau, N. Y., Kamath, A. V., Manley, C. M., Lilley, S. C., Otte, D. A. L., Scott, D. O., Sheils, A. L., Tess, D. A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.005 · Cited by 36
Casteel, D. E., Smith‐Nguyen, E. V., Sankaran, B., Roh, S. H., Pilz, R. B., & Kim, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.161430 · Cited by 35
Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
Nikolova, S., Günther, A., Savai, R., Weißmann, N., Ghofrani, H. A., Königshoff, M., Eickelberg, O., Klepetko, W., Voswinckel, R., Seeger, W., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-146 · Cited by 26
A Novel PDE2A Reporter Cell Line: Characterization of the Cellular Activity of PDE Inhibitors
Wunder, F., Gnoth, M. J., Geerts, A., & Barufe, D. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800127n · Cited by 25
The discovery and synthesis of highly potent subtype selective phosphodiesterase 4D inhibitors
Aspiotis, R., Deschênes, D., Dubé, D., Girard, Y., Huang, Z., Laliberté, F., Liu, S., Papp, R., Nicholson, D. W., & Young, R. N. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.076 · Cited by 22
Rentsendorj, O., Damarla, M., Aggarwal, N. R., Choi, J., Johnston, L., D’Alessio, F. R., Crow, M. T., & Pearse, D. B. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00073.2011 · Cited by 21
Demirbas, D., Ceyhan, O., Wyman, A. R., Ivey, F. D., Allain, C. J., Wang, L., Sharuk, M. N., Francis, S. H., & Hoffman, C. S. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.013 · Cited by 20
Phosphodiesterase 5: Molecular Characteristics Relating to Structure, Function, and Regulation
Francis, S. H., Zoraghi, R., Kotera, J., Ke, H., Bessay, E. P., Blount, M. A., & Corbin, J. D. (2006) · CRC Press eBooks · doi:10.1201/9781420020847-7 · Cited by 20
Murray, F., MacLean, M. R., & Pyne, N. J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705190 · Cited by 18
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
Houslay, M. D. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.004 · Cited by 17
Cho, E. S., Yu, J. H., Kim, M. S., & Yim, M. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.1.149 · Cited by 13
Degerman, E., & Manganiello, V. (2006) · CRC Press eBooks · doi:10.1201/9781420020847-5 · Cited by 10
Menniti, F. S., Schmidt, C. J., & Strick, C. A. (2006) · CRC Press eBooks · doi:10.1201/9781420020847.ch12 · Cited by 10
Cited by
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
PDE5 inhibitors – pharmacology and clinical applications 20 years after sildenafil discovery
Andersson, K. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14205 · Cited by 445
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Vigano, S., Alatzoglou, D., Irving, M., Ménétrier-Caux, C., Caux, C., Romero, P., & Coukos, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00925 · Cited by 420
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
Azevedo, M. F., Faucz, F. R., Bimpaki, E., Horvath, A., Levy, I., de Alexandre, R. B., Ahmad, F., Manganiello, V., & Stratakis, C. A. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1053 · Cited by 325
Metadata
- Authors
- Keravis, T., & Lugnier, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-02-10
- Volume
- 165
- Issue
- 5
- Pages
- 1288-1305
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2164088711
- Cited by
- 385
- References
- 150
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.